Otsuka Holdings Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 38,210
Employees
  • Stock Symbol
  • 4578
Stock Symbol
  • Investments
  • 10
  • Share Price
  • $34.74
  • (As of Friday Closing)

Otsuka Holdings General Information

Description

Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.

Contact Information

Website
www.otsuka.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Shinagawa Grand Central Tower
  • 2-16-4 Konan, Minato-ku
  • Tokyo, 108-8241
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Otsuka Holdings Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.74 $35.06 $31.78 - $45.48 $18.8B 542M 1M $1.71

Otsuka Holdings Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 17,207,412 17,676,883 22,027,616 23,281,252
Revenue 13,723,966 13,643,772 13,324,512 12,806,595
EBITDA 1,885,694 2,179,614 2,603,477 2,313,908
Net Income 926,046 1,142,505 1,387,277 1,166,255
Total Assets 23,646,670 24,514,561 25,480,005 23,704,161
Total Debt 1,735,981 1,846,278 2,192,130 2,326,201
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Otsuka Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Otsuka Holdings‘s full profile, request access.

Request a free trial

Otsuka Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Busin
Drug Discovery
Tokyo, Japan
38,210 As of 2021
00.000
00000000 00.000

00000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
0000 000000000
Mumbai, India
00000 As of 0000
00000000

0000 000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Otsuka Holdings Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
00000000 Formerly VC-backed Dublin, Ireland 0000 00.000 000000000 00.000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
000000000000 00000 Corporate Backed or Acquired Boca Raton, FL 000000&0
You’re viewing 5 of 28 competitors. Get the full list »

Otsuka Holdings Patents

Otsuka Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170315118-A1 Method for measuring anti-drug antibody Granted 27-Apr-2016 0000000000
ES-2765808-T3 Method for measuring anti-drug antibodies Active 27-Apr-2016 000000000
US-10295534-B2 Method for measuring anti-drug antibody Active 27-Apr-2016 0000000000 0
JP-2017201310-A Method for measuring anti-drug antibodies Granted 27-Apr-2016 0000000000
JP-6170644-B1 Anti-drug antibody measurement method Active 27-Apr-2016 G01N33/564
To view Otsuka Holdings’s complete patent history, request access »

Otsuka Holdings Executive Team (8)

Name Title Board Seat Contact Info
Yuko Makino Chief Financial Officer, Finance & Board Member
Andrew Goodman Senior Analyst, Global Strategy & Planning
Tatsuo Higuchi Chief Executive Officer & Chairman
You’re viewing 3 of 8 executive team members. Get the full list »

Otsuka Holdings Board Members (7)

Name Representing Role Since
0000 0000 Otsuka Holdings Board Member 000 0000
000000 0000 Self Board Member 000 0000
000000 0000000 Self Chief Executive Officer & Chairman 000 0000
000000000 0000 Otsuka Holdings Board Member 000 0000
00000 000000000 Otsuka Holdings Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Otsuka Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Otsuka Holdings Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 25-Sep-2018 00000 0000 0000 Private Equity
00000 0000000 10-Jul-2018 0000000000 Therapeutic Devices 000000 00
000000 000000 21-Sep-2017 000000000 0000 Pharmaceuticals
00000 00000 31-Aug-2017 0000000000 00000 Food Products 000000 00
Neurovance 01-Mar-2017 Merger/Acquisition 00000 Drug Discovery 000000 00
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Otsuka Holdings Subsidiaries (5)

Company Name Industry Location Founded
Recor Medical Therapeutic Devices Palo Alto, CA 2009
00000 00000 Food Products Vancouver, Canada 0000
00000 000000 00000 Drug Delivery Cairo, Egypt 0000
00000 000000000000 Corporation Tokyo, Japan 0000
0000 00000000 Corporate Venture Capital Sherman Oaks, CA
To view Otsuka Holdings’s complete subsidiaries history, request access »